Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
84.67
-2.62 (-3.01%)
Streaming Delayed Price
Updated: 11:24 AM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Stocks Near Pre-COVID Highs - Thursday, May 19
May 19, 2022
The S&P 500 is still up over 15% relative to its pre-COVID high, but as of yesterday’s close, 41.2% of S&P 500 members were below their respective pre-COVID highs as 26 members crossed below this...
Via
Talk Markets
Dexcom Announces Upcoming Conference Presentations
May 10, 2022
From
DexCom, Inc.
Via
Business Wire
If You Invested $1000 In DexCom 10 Years Ago, Here's How Much You Would Have Today
May 02, 2022
DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 32.66% on an annualized basis producing an average annual return of 44.4%. Currently, DexCom has a market capitalization of...
Via
Benzinga
Read Here Why Did This Analyst Cut DexCom's Price Target
April 29, 2022
Via
Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
April 29, 2022
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings.
Via
Investor's Business Daily
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
April 28, 2022
From
DexCom, Inc.
Via
Business Wire
Recap: DexCom Q1 Earnings
April 28, 2022
DexCom (NASDAQ:DXCM) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by...
Via
Benzinga
Dexcom Stock Ticks Lower On Mixed First-Quarter Report
April 28, 2022
Dexcom dipped on light first-quarter profit, though sales narrowly beat forecasts.
Via
Investor's Business Daily
Dexcom Reports First Quarter 2022 Financial Results
April 28, 2022
From
DexCom, Inc.
Via
Business Wire
DexCom Stock Falls As Q4 Profit, FY22 Sales Outlook Trail Wall Street Estimates
February 11, 2022
DexCom Inc's (NASDAQ: DXCM)
Via
Benzinga
Insulet Highlights New Data For Omnipod 5 System For Type 1, Type 2 Diabetes
April 27, 2022
Insulet Corporation (NASDAQ: PODD) unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes patients. Paired with...
Via
Benzinga
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
April 26, 2022
From
DexCom, Inc.
Via
Business Wire
Markets Fall Sharply Amid Ongoing Rate Hike Concerns
April 22, 2022
The S&P 500 traded lower for the third week in a row as investors brace for a potential 0.5% interest rate hike by the Federal Reserve. U.S. indices traded sharply lower...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 19, 2022
Gainers
Via
Benzinga
Dexcom Publishes Annual Sustainability Report
April 07, 2022
From
DexCom, Inc.
Via
Business Wire
Here's How Much $100 Invested In DexCom 5 Years Ago Would Be Worth Today
April 06, 2022
DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 32.15% on an annualized basis producing an average annual return of 45.92%. Currently, DexCom has a market capitalization of...
Via
Benzinga
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard
April 01, 2022
Medical and gold stocks led the S&P 500. Transport stocks were big losers.
Via
Investor's Business Daily
Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time
March 31, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Stock Shows Market Leadership With Jump To 86 RS Rating
March 30, 2022
Dexcom shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.
Via
Investor's Business Daily
Markets Have Another Strong Week As S&P 500 Erases Initial Losses From Russia-Ukraine War
March 25, 2022
U.S. indices finished mixed Friday to conclude the trading week. Oil prices gained during Friday's session, which has continued to pressure economic sentiment. The S...
Via
Benzinga
Dexcom Announces Four-for-One Forward Stock Split
March 25, 2022
From
DexCom, Inc.
Via
Business Wire
Markets Fall In Anticipation Of This Week's Fed Decision
March 14, 2022
U.S. indices finished lower Monday amid continued Russia-Ukraine uncertainty, as well as in anticipation of this week’s Fed decision. The Nasdaq composite finished lower by...
Via
Benzinga
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
March 14, 2022
From
DexCom, Inc.
Via
Business Wire
Dexcom Snags A New Diabetes Device Win After Covid-Related Delay
March 14, 2022
Dexcom won out in Europe after the pandemic slowed its G7 CGM.
Via
Investor's Business Daily
Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark
March 14, 2022
DexCom Inc's (NASDAQ: DXCM) Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older...
Via
Benzinga
Could A Simple Device Help Revolutionize Medical Diagnostics? This Company Thinks So
March 04, 2022
Image provided by Know Labs This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Know...
Via
Benzinga
DexCom's Glucose Monitoring System Snags Breakthrough Device Tag For Hospital Use
March 02, 2022
The FDA granted Breakthrough Device Designation for DexCom Inc (NASDAQ: DXCM) for continuous glucose monitoring (CGM) use in the hospital setting. Dexcom CGM...
Via
Benzinga
Dexcom Announces Upcoming Virtual Conference Presentations
February 14, 2022
From
DexCom, Inc.
Via
Business Wire
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
Recap: DexCom Q4 Earnings
February 10, 2022
DexCom (NASDAQ:DXCM) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.